ZVRA
Zevra Therapeutics Inc.
11.00$
-0.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -184.9% | -14.6% | 36.4% | -184.2% | -122.1% | -295.0% | -1.5% | |
| – | – | – | – | – | 2.4% | 2.1% | 0.9% | 9.3% | 3.7% | 27.1% | 3.8% | |
| – | – | – | – | – | 34.3% | 18.7% | 8.5% | 42.3% | 21.7% | 63.1% | 11.9% | |
| – | – | – | – | – | 29.8% | 59.2% | 66.1% | 219.9% | – | – | – | |
| – | – | – | – | – | -39.9% | 2.8% | -1.2% | -4.0% | 21.4% | -28.1% | -24.9% | |
| – | – | – | – | – | 0.2% | 0.2% | 0.4% | 0.9% | 1.1% | 0.0% | 0.8% | |
| – | – | – | – | – | 25.2% | -0.2% | -54.2% | -361.4% | -63.3% | -93.9% | 17.0% | |
| – | – | – | – | – | – | – | 107.6% | 3.2% | – | – | – | |
| – | – | – | – | – | – | 0.0% | -9.8% | -46.5% | -12.6% | 0.0% | – | |
| – | – | – | – | – | -1.6% | 4.2% | -133.0% | 125.5% | 90.7% | 69.0% | 0.0% | |
| – | – | – | – | – | 38.5% | 20.6% | 394.8% | 82.2% | 103.7% | 347.7% | 11.3% | |
| – | – | – | – | – | -121.2% | 5.8% | 377.0% | -461.4% | -81.6% | -39.2% | 26.9% | |
| – | – | – | – | – | -185.1% | -14.8% | 36.1% | -185.1% | -123.2% | -295.0% | -2.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.